NCT02716870 Meta-analyses of the Effect of Important Food Sources of Sugars on Cardiometabolic Risk Factors Status UNKNOWN Phase N/A
NCT02702479 Meta-analyses of the Effect of Sucrose Versus High Fructose Corn Syrup on Cardiometabolic Risk Status UNKNOWN Phase N/A
NCT02702375 Meta-analyses of Impotrant Food Sources of Sugars and Incident Cardiometabolic Diseases Status UNKNOWN Phase N/A
NCT02648269 Safety and Pharmacodynamics of SEL-212 (Pegsiticase + SEL-110) in Subjects With Elevated Blood Uric Acid Levels Status COMPLETED Phase PHASE1
NCT02598596 Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect Status COMPLETED Phase PHASE2
NCT02579096 CSP594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat Status COMPLETED Phase PHASE4
NCT02578394 Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility Study Status COMPLETED Phase PHASE2/PHASE3
NCT02557126 Study of URC102 to Assess the Safety and Efficacy in Gout Patients Status COMPLETED Phase PHASE2
NCT02500641 Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout Status COMPLETED Phase PHASE4
NCT02498652 Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects Status COMPLETED Phase PHASE2
NCT02464605 Safety and Pharmacodynamics of SEL-037 (Pegsiticase) in Subjects With Elevated Blood Uric Acid Levels Status COMPLETED Phase PHASE1
NCT02330796 Bucillamine for the Treatment of Acute Gout Flare in Subjects With Moderate to Severe Gout Status COMPLETED Phase PHASE2